Companies Dominating the Subcutaneous Implantable Defibrillator Landscape
- Boston Scientific Corporation,
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- LivaNova PLC Company,
- Imricor Medical Systems, Inc.,
- MicroPort Scientific Corporation
- Mayo Clinic US, Medtronic plc
- MRI Interventions, Inc.,
- St. Jude Medical, Inc.,
Boston Scientific Corporation and Medtronic are the leading organizations dealing in subcutaneous implantable defibrillator market. Boston Scientific Corporation, EMBLEM MRI S-ICD, is known for providing protection from sudden cardiac death. This device is also known to mitigate the risks and complications that are associated with the transvenous leads. Moreover, other market players are working towards innovations in market to provide a wide range of products over the coming years.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of subcutaneous implantable defibrillator is evaluated at USD 9.36 billion.
Subcutaneous Implantable Defibrillator Market size was valued at USD 9.02 billion in 2024 and is set to exceed USD 15.79 billion by 2037, registering over 4.4% CAGR during the forecast period i.e., between 2025-2037.
North America industry is estimated to dominate majority revenue share by 2037, led by rising geriatric population, and availability of advanced treatment options in the region.
The major players in the market are Boston Scientific Corporation, LivaNova PLC Company, Imricor Medical Systems, Inc., MicroPort Scientific Corporation, Mayo Clinic US, Medtronic plc, MRI Interventions, Inc., and St. Jude Medical, Inc., and others.
